Abstract
Objective: To determine if mental health service utilization increases when patients are converted to generic clozapine.
Method: About 125 patients taking clozapine in a community mental health clinic were switched from Novartis Clozaril to generic clozapine (Mylan Pharmaceuticals). Serum clozapine levels were obtained 2 weeks before, and 2 weeks after, the switch to generic clozapine. The number of outpatient visits, emergency room visits, and hospitalizations in the year prior to the switch were compared to those in the year following the switch, to determine service utilization.
Results: Psychiatric emergency room visits decreased, but clozapine serum levels, inpatient hospital days, partial hospital admissions, and outpatient psychiatrist visits did not change after the switch to generic clozapine.
Conclusions: There were no significant increases in mental health service utilization after the conversion to Mylan generic clozapine. The switch to Mylan generic clozapine was cost effective, as the reduction in pharmacy costs was not offset by increased utilization costs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
N. R. Cutler (2001) ArticleTitlePharmacokinetic studies of antipsychotics in healthy volunteers versus patients Journal of Clinical Psychiatry 62 IssueIDSuppl 5 10–13
InstitutionalAuthorNameExpert Consensus Guideline Series (2003) ArticleTitleOptimizing pharmacologic treatment of psychotic disorders Journal of Clinical Psychiatry 64 IssueIDSuppl 12 1–100
J. C. Kluznik N. H. Walbek M. G. Farnsworth K. Melstrom (2001) ArticleTitleClinical effects of a randomized switch of patients from clozaril to generic clozapine Journal of Clinical Psychiatry 62 IssueIDSuppl 5 14–17
Y. W. Lam L. Ereshefsky G. B. Toney C. Gonzales (2001) ArticleTitleBranded versus generic clozapine: bioavailability comparison and interchangeability issues Journal of Clinical Psychiatry 62 IssueIDSuppl 5 18–22
E. H. Makela W. D. Cutlip J. M. Stevenson J. M. Weimer E. S. Abdallah R. S. Akhtar A. S. Aboraya E. Gunel (2003) ArticleTitleBranded versus generic clozapine for treatment of schizophrenia Annals of Pharmacotherapy 37 350–353
R. Mofsen J. Balter (2001) ArticleTitleCase reports of the reemergence of psychotic symptoms after conversion from brand-name clozapine to a generic formulation Clinical Therapeutics 23 1720–1731
T. A. Sajbel G. W. Carter R. B. Wiley (2001) ArticleTitleConverting patients from brand-name clozapine to generic clozapine Annals of Pharmacotherapy 35 281–284
S. C. Stoner J. W. Lea B. Dubisar P. A. Marken L. V. Ramlatchman J. Reynolds (2003) ArticleTitleA program to convert patients from trade-name to generic clozapine Pharmacotherapy 23 806–810
G. Tse D. Thompson R. M. Procyshyn (2003) ArticleTitleGeneric clozapine: a cost-saving alternative to brand name clozapine? Pharmacoeconomics 21 1–11
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Healy, D.J., Taylor, S., Goldman, M. et al. Clinical Equivalence of Generic Clozapine. Community Ment Health J 41, 393–398 (2005). https://doi.org/10.1007/s10597-005-5981-y
Issue Date:
DOI: https://doi.org/10.1007/s10597-005-5981-y